Aptamers as Theragnostic Tools in Prostate Cancer

Despite of the capacity that several drugs have for specific inhibition of the androgen receptor (AR), in most cases, PCa progresses to an androgen-independent stage. In this context, the development of new targeted therapies for prostate cancer (PCa) has remained as a challenge. To overcome this is...

Descripción completa

Detalles Bibliográficos
Autores principales: Cruz-Hernández, Carlos David, Rodríguez-Martínez, Griselda, Cortés-Ramírez, Sergio A., Morales-Pacheco, Miguel, Cruz-Burgos, Marian, Losada-García, Alberto, Reyes-Grajeda, Juan Pablo, González-Ramírez, Imelda, González-Covarrubias, Vanessa, Camacho-Arroyo, Ignacio, Cerbón, Marco, Rodríguez-Dorantes, Mauricio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406110/
https://www.ncbi.nlm.nih.gov/pubmed/36008950
http://dx.doi.org/10.3390/biom12081056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406110/
https://www.ncbi.nlm.nih.gov/pubmed/36008950
http://dx.doi.org/10.3390/biom12081056

Ejemplares similares